「临床可忽略」的残余肾功能对尿毒症溶质清除仍有贡献
本研究基于血液透析研究中的1280例患者,评估「临床可忽略」残余肾功能(RKF,尿尿素清除率≤1.5 mL/min)对非尿素溶质清除的影响。结果显示,34%患者有临床可忽略RKF(均值0.7±0.4 mL/min),其8种非尿素溶质中7种水平显著低于无RKF者,且1年随访时保留RKF与较低心脏死亡和心血管事件风险相关。
要点
- 临床可忽略RKF(均值0.7 mL/min)仍显著降低多种尿毒症溶质水平。
- RKF对溶质清除的效果相当于或优于透析剂量增加31%。
- 1年随访保留RKF与较低心脏死亡及心血管事件风险相关。
核心结论
- 即使RKF水平很低,也并非「可忽略」,仍提供非尿素溶质清除。
研究设计与样本
- 研究纳入血液透析研究中的1280例患者,测量8种非尿素溶质,依据尿尿素清除率分组比较。
主要发现
- 34%患者有临床可忽略RKF(均值0.7±0.4 mL/min),66%无RKF。
- 8种非尿素溶质中7种在有RKF者中显著更低,如马尿酸低24%(95%CI -31至-16)、TMAO低7%(-14至-1)、ADMA低4%(-6至-1)。
- RKF对血浆溶质水平的影响相当于或优于透析剂量增加31%(spKt/Vurea 1.7 vs 1.3)。
- 1年随访保留RKF与较低心脏死亡和首次心血管事件风险相关。
关键数值与推荐
- 尿尿素清除率≤1.5 mL/min被定义为「临床可忽略」RKF。
- 有RKF者马尿酸水平低24%(95%CI -31至-16),TMAO低7%(-14至-1),ADMA低4%(-6至-1)。
临床怎么用
- 管理RKF患者时应考虑即使低水平RKF仍对溶质清除有临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Residual kidney function (RKF) is thought to exert beneficial effects through clearance of uremic toxins. However, the level of native kidney function where clearance becomes negligible is not known. METHODS: We aimed to assess whether levels of nonurea solutes differed among patients with 'clinically negligible' RKF compared with those with no RKF. The hemodialysis study excluded patients with urinary urea clearance >1.5 mL/min, below which RKF was considered to be 'clinically negligible'. We measured eight nonurea solutes from 1280 patients participating in this study and calculated the relative difference in solute levels among patients with and without RKF based on measured urinary urea clearance. RESULTS: The mean age of the participants was 57 years and 57% were female. At baseline, 34% of the included participants had clinically negligible RKF (mean 0.7 ± 0.4 mL/min) and 66% had no RKF. Seven of the eight nonurea solute levels measured were significantly lower in patients with RKF than in those without RKF, ranging from -24% [95% confidence interval (CI) -31 to -16] for hippurate, -7% (-14 to -1) for trimethylamine-N-oxide and -4% (-6 to -1) for asymmetric dimethylarginine. The effect of RKF on plasma levels was comparable or more pronounced than that achieved with a 31% higher dialysis dose (spKt/Vurea 1.7 versus 1.3). Preserved RKF at 1-year follow-up was associated with a lower risk of cardiac death and first cardiovascular event. CONCLUSIONS: Even at very low levels, RKF is not 'negligible', as it continues to provide nonurea solute clearance. Management of patients with RKF should consider these differences.
引用
- Toth-Manikowski SM, Sirich TL, Meyer TW, et al. Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes. Nephrol Dial Transplant. 2020. PMID: 30879076. doi:10.1093/ndt/gfz042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。